开发用于蛋白质降解的双受体溶酶向基因组
Kun Wang1, Ke Wang2, Cong Wang2
1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Journal of the American Chemical Society
|October 23, 2025
概括
这项研究引入了一种使用 lysosome-targeting chimeras (LYTACs) 来降解 PD-L1 和 EGFR 等引起疾病的蛋白质的双重向策略. 这种新的方法提高了潜在的癌症治疗的向蛋白质降解.
科学领域:
- 生物化学
- 分子生物学
- 癌症学
背景情况:
- 色素向性仿真体 (LYTAC) 是针对蛋白质降解的新兴疗法.
- 目前的LYTAC策略在降解特定的细胞外和膜蛋白质方面存在局限性.
研究的目的:
- 开发一种新的双溶酶体向受体依赖的蛋白质降解策略.
- 创建双受体LYTAC以有效降解编程细胞死亡配体1 (PD-L1) 和表皮生长因子受体 (EGFR).
主要方法:
- 通过C-X-C化学因子受体4 (CXCR4) 和叶酸受体1 (FOLR1) 的协同作用.
- 为PD-L1和EGFR降解设计和测试的双受体LYTAC.
- 在EGFR驱动肺癌的临床前模型中评估疗效.
主要成果:
- 使用双受体LYTAC实现了PD- L1和EGFR的高效溶酶分解.
- 这种向EGFR的基因组显著抑制了耐药性肺癌瘤的生长.
- 与单个受体LYTAC相比,双重向策略显示出更高的蛋白质降解.
结论:
- 双重向的LYTAC策略提供了增强的蛋白质降解能力.
- 这种新的平台有望开发先进的癌症疗法.
- 双受体向代表了治疗疾病的蛋白质降解策略的重大进展.
相关概念视频
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Delivery Pathways to the Lysosome
8.8K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.8K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Receptor-mediated Endocytosis
110.5K
Overview
110.5K
Receptor-mediated Endocytosis
7.5K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.5K
Export of Misfolded Proteins out of the ER
5.0K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.0K


